Home Amines 105512-81-0
105512-81-0,MFCD00170238
Catalog No.:AA003GBB

105512-81-0 | 2-Amino-4-(3-bromophenyl)thiazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$29.00   $21.00
- +
250mg
98%
in stock  
$36.00   $25.00
- +
1g
98
in stock  
$75.00   $53.00
- +
5g
98%
in stock  
$261.00   $183.00
- +
10g
98%
in stock  
$477.00   $334.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003GBB
Chemical Name:
2-Amino-4-(3-bromophenyl)thiazole
CAS Number:
105512-81-0
Molecular Formula:
C9H7BrN2S
Molecular Weight:
255.1343
MDL Number:
MFCD00170238
SMILES:
Brc1cccc(c1)c1csc(n1)N
Properties
Properties
 
BP:
398.8°C at 760 mmHg  
Form:
Solid  
MP:
130-131 °C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
179  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
3  

Downstream Synthesis Route
105512-81-0   
C18H12Br2N4S4 

[1]Siddiqui,HamidLatif;Zia-Ur-Rehman,Muhammad;Ahmad,Naveed;Weaver,GeorgeWilliam;Lucas,PaulDavid[ChemicalandPharmaceuticalBulletin,2007,vol.55,#7,p.1014-1017]

[1]Siddiqui,HamidLatif;Zia-Ur-Rehman,Muhammad;Ahmad,Naveed;Weaver,GeorgeWilliam;Lucas,PaulDavid[ChemicalandPharmaceuticalBulletin,2007,vol.55,#7,p.1014-1017]

[2]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2020/160180,2020,A1Locationinpatent:Page/Pagecolumn87

[3]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2020/160100,2020,A1Locationinpatent:Page/Pagecolumn31

[4]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/155316,2021,A1Locationinpatent:Page/Pagecolumn64;84-85;144

[5]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/155321,2021,A2Locationinpatent:Page/Pagecolumn212-213

[6]Özbek,Oguz;Usta,NecibeCanan;Gürdere,MelihaBurcu;Aslan,OsmanNuri;Budak,Yakup;Ceylan,Mustafa[Phosphorus,SulfurandSiliconandtheRelatedElements,2017,vol.192,#10,p.1153-1157]

[7]Chen,Lingfeng;Chen,Hongjin;Chen,Pengqin;Zhang,Wenxin;Wu,Chao;Sun,Chuchu;Luo,Wu;Zheng,Lulu;Liu,Zhiguo;Liang,Guang[EuropeanJournalofMedicinalChemistry,2019,vol.161,p.22-38]

[8]Joshi,ShrinivasD.;Kumar,S.R.Prem;Patil,Sonali;Vijayakumar;Kulkarni,VenkataraoH.;Nadagouda,MallikarjunaN.;Badiger,AravindM.;Lherbet,Christian;Aminabhavi,TejrajM.[MedicinalChemistryResearch,2019,vol.28,#11,p.1838-1863]

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2006/76702,2006,A1Locationinpatent:Page/Pagecolumn65-66

[1]ChellappaSubramanyam,DwarakaViswanath;Divi,Haranath;Godugu,Kumar;Gundala,TrivikramReddy;Loka,SubramanyamSarma;MohinuddinPinjari,MohammadKhaja;ReddyNallagondu,ChinnaGangi;Shaik,Sultana;Vemula,Venkatramu[DyesandPigments,2021,vol.187]

[2]Locationinpatent:experimentalpartGaikwad,SudhakarA.;Patil,AmolA.;Deshmukh,MadhukarB.[Phosphorus,SulfurandSiliconandtheRelatedElements,2010,vol.185,#1,p.103-109]

[3]Yan,Gang;Hao,Lina;Niu,Yan;Huang,Wenjie;Wang,Wei;Xu,Fengrong;Liang,Lei;Wang,Chao;Jin,Hongwei;Xu,Ping[EuropeanJournalofMedicinalChemistry,2017,vol.137,p.462-475]

[4]Annadurai,Sivakumar;Martinez,Rogelio;Canney,DanielJ.;Eidem,Tess;Dunman,PaulM.;Abou-Gharbia,Magid[BioorganicandMedicinalChemistryLetters,2012,vol.22,#24,p.7719-7725]

[5]CurrentPatentAssignee:UNIVERSITYOFLYON;UNIVERSITYOFGENEVA;THEUNIVERSITYOFMILANO-BICOCCA-WO2015/1024,2015,A1Locationinpatent:Page/Pagecolumn71

[6]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/236080,2021,A1Locationinpatent:Page/Pagecolumn56-57

[7]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/236080,2021,A1Locationinpatent:Page/Pagecolumn56-57

[8]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-US2022/79940,2022,A1Locationinpatent:Paragraph0292;0295-0296

[9]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2006/76702,2006,A1Locationinpatent:Page/Pagecolumn65-66

[10]Ran,Kai;Gao,Chao;Deng,Hongxia;Lei,Qian;You,Xinyu;Wang,Ningyu;Shi,Yaojie;Liu,Zhihao;Wei,Wei;Peng,Cuiting;Xiong,Lu;Xiao,Kunjie;Yu,Luoting[BioorganicandMedicinalChemistryLetters,2016,vol.26,#15,p.3669-3674]

[11]Gundala,TrivikramReddy;Godugu,Kumar;Nallagondu,ChinnaGangiReddy[JournaloftheChineseChemicalSociety,2017,vol.64,#12,p.1408-1416]

[12]Ma,Chunhua;Miao,Yuqi;Zhao,Minghao;Wu,Ping;Zhou,Jianglu;Li,Zhi;Xie,Xilei;Zhang,Wei[Tetrahedron,2018,vol.74,#27,p.3602-3607]

[13]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2019/152437,2019,A1Locationinpatent:Page/Pagecolumn164

[14]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2020/160100,2020,A1Locationinpatent:Page/Pagecolumn88

[15]El-Dash,Yara;Elzayat,Emad;Abdou,AmrM.;Hassan,RashaA.[BioorganicChemistry,2021,vol.114]

[16]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-US2021/230154,2021,A1Locationinpatent:Paragraph0203-0204

[17]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/155320,2021,A1Locationinpatent:Page/Pagecolumn317

[18]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/155316,2021,A1Locationinpatent:Page/Pagecolumn416

[1]Annadurai,Sivakumar;Martinez,Rogelio;Canney,DanielJ.;Eidem,Tess;Dunman,PaulM.;Abou-Gharbia,Magid[BioorganicandMedicinalChemistryLetters,2012,vol.22,#24,p.7719-7725]

Literature

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:105512-81-0 Molecular Formula|105512-81-0 MDL|105512-81-0 SMILES|105512-81-0 2-Amino-4-(3-bromophenyl)thiazole